The operating environment for In Vitro Diagnostics (IVD) is changing rapidly and getting more complex. Regulators and Payers are increasing policy scrutiny, diagnostic solutions require more and better clinical evidence and digital diagnostic solutions challenge the status quo. On the other hand, health care systems face significant cost pressure, innovation cycles are getting shorter and solutions more technologically advanced.
This Webinar will explore how Health Technology Assessments for diagnostics play an ever-growing role in this transition. The talk will briefly cover:
IVD’s in hospitals use and the DRG system - Mattias
Comparing HTA results for IVDs in Germany, France, and the UK - Mattias
Cover the key trends leading to more Diagnostics HTA's in Europe - Norbert
Compare 5 diagnostics relevant to HTA practices on policy, scientific and country-level - Norbert
Highlight some interesting examples for future trends - Norbert
Interactive Q&A
Speakers:
Norbert Farkas, Founder and managing partner of CENTIVIS
Mattias Kyhlstedt, CEO and founder of Synergus RWE